| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0009 | 1 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.00067 | 1 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.00063 | 1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.0006 | 1 |